{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T01:33:26Z","timestamp":1771378406394,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"JSPS KAKENHI","award":["JP21K08396"],"award-info":[{"award-number":["JP21K08396"]}]},{"name":"The Kochi Medical School Hospital President\u2019s Discretionary Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12185-025-04076-z","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:44:03Z","timestamp":1758872643000},"page":"189-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Myelodysplastic neoplasms with unbalanced whole-arm translocation der(5;19)(p10;q10): association with double-hit TP53 mutations"],"prefix":"10.1007","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4138-0604","authenticated-orcid":false,"given":"Kensuke","family":"Kojima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Tsuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Umebara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshie","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Asagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"4076_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.leukres.2008.08.015","volume":"33","author":"K Yamamoto","year":"2009","unstructured":"Yamamoto K, Okamura A, Katayama Y, Shimoyama M, Matsui T. Unbalanced whole-arm translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in myelodysplastic syndrome. Leuk Res. 2009;33:377\u201383.","journal-title":"Leuk Res"},{"key":"4076_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.08.033","volume":"34","author":"K Yamamoto","year":"2010","unstructured":"Yamamoto K, Wakahashi K, Okamura A, Katayama Y, Shimoyama M, Matsui T. Two further cases of myelodysplastic syndrome and acute myeloid leukemia with der(5;19)(p10;q10): association with abnormalities involving chromosomes 12 and 21. Leuk Res. 2010;34:e38\u201341.","journal-title":"Leuk Res"},{"key":"4076_CR3","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1111\/ajco.12051","volume":"10","author":"M Manabe","year":"2014","unstructured":"Manabe M, Takakuwa T, Nakano H, Harada N, Okamoto S, Aoyama Y, et al. Derivative (5;19)(p10;q10): a rare but recurrent whole-arm translocation in acute myeloid leukemia. Asia Pac J Clin Oncol. 2014;10:e122\u20136.","journal-title":"Asia Pac J Clin Oncol"},{"key":"4076_CR4","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1111\/j.1525-1438.2007.01185.x","volume":"18","author":"S Yeasmin","year":"2008","unstructured":"Yeasmin S, Nakayama K, Ishibashi M, Oride A, Katagiri A, Purwana IN, et al. Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel- and carboplatin-based chemotherapy in an ovarian cancer patient: a case report and literature review. Int J Gynecol Cancer. 2008;18:1371\u20136.","journal-title":"Int J Gynecol Cancer"},{"key":"4076_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s12185-016-2160-6","volume":"105","author":"H Ureshino","year":"2017","unstructured":"Ureshino H, Kizuka H, Kusaba K, Sano H, Nishioka A, Shindo T, et al. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10). Int J Hematol. 2017;105:692\u20136.","journal-title":"Int J Hematol"},{"issue":"11","key":"4076_CR6","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200\u201328.","journal-title":"Blood"},{"key":"4076_CR7","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022;36:1703\u201319.","journal-title":"Leukemia"},{"key":"4076_CR8","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1182\/blood.2021014472","volume":"139","author":"T Grob","year":"2022","unstructured":"Grob T, Al Hinai ASA, Sanders MA, Kavelaars FG, Rijken M, Gradowska PL, et al. Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome. Blood. 2022;139:2347\u201354.","journal-title":"Blood"},{"key":"4076_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3816\/CLK.2008.n.012","volume":"2","author":"A Matsuda","year":"2008","unstructured":"Matsuda A, Jinnai I, Miyazaki Y, Tomonaga M. Proposals for a grading system for diagnostic accuracy of myelodysplastic syndromes. Clin Leukemia. 2008;2:102\u20136.","journal-title":"Clin Leukemia"},{"key":"4076_CR10","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sol\u00e9 F, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120:2454\u201365.","journal-title":"Blood"},{"key":"4076_CR11","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1182\/bloodadvances.2023010312","volume":"7","author":"A Stengel","year":"2023","unstructured":"Stengel A, Meggendorfer M, Walter W, Baer C, Nadarajah N, Hutter S, et al. Interplay of TP53 allelic state, blast count, and complex karyotype on survival of patients with AML and MDS. Blood Adv. 2023;7:5540\u20138.","journal-title":"Blood Adv"},{"key":"4076_CR12","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/s41591-020-1008-z","volume":"26","author":"E Bernard","year":"2020","unstructured":"Bernard E, Nannya Y, Hasserjian RP, Devlin SM, Tuechler H, Medina-Martinez JS, et al. Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes. Nat Med. 2020;26:1549\u201356.","journal-title":"Nat Med"},{"key":"4076_CR13","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1182\/bloodadvances.2021006239","volume":"6","author":"OK Weinberg","year":"2022","unstructured":"Weinberg OK, Siddon A, Madanat YF, Gagan J, Arber DA, Dal Cin P, et al. TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS\/AML. Blood Adv. 2022;6:2847\u201353.","journal-title":"Blood Adv"},{"key":"4076_CR14","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/sj.leu.2401067","volume":"12","author":"A Venditti","year":"1998","unstructured":"Venditti A, Del Poeta G, Buccisano F, Tamburini A, Cox-Froncillo MC, Aronica G, et al. Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia. Leukemia. 1998;12:1056\u201363.","journal-title":"Leukemia"},{"key":"4076_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1182\/bloodadvances.2023010417","volume":"8","author":"MT Nawas","year":"2024","unstructured":"Nawas MT, Kosuri S. Utility or futility? A contemporary approach to allogeneic hematopoietic cell transplantation for TP53-mutated MDS\/AML. Blood Adv. 2024;8:553\u201361.","journal-title":"Blood Adv"},{"key":"4076_CR16","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41375-018-0351-2","volume":"33","author":"D Haase","year":"2019","unstructured":"Haase D, Stevenson KE, Neuberg D, Maciejewski JP, Nazha A, Sekeres MA, et al. TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Leukemia. 2019;33:1747\u201358.","journal-title":"Leukemia"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04076-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-04076-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04076-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:50:42Z","timestamp":1771339842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-04076-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4076"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-04076-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinicopathological studies, including NGS analysis, were approved by the Ethics Committee of the Kochi Medical School Hospital (No. 2023-94). Written informed consent was obtained from all the patients for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Kensuke Kojima has received lecture fees from AstraZeneca K.K., Janssen Pharmaceutical K.K., AbbVie G.K., BeOne Medicines G.K., and Nippon Shinyaku Co., Ltd.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}